← Portfolio Scout

Portfolio company

ARS Pharmaceuticals

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

2 investors

Sectors

Digital HealthConsumer Wellbeing

About

ARS Pharmaceuticals develops a needle-free nasal spray for patients and caregivers to treat severe allergic reactions, including anaphylaxis.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies